Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Skin Neoplasms 6Neoplasms 6Melanoma 5Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Squamous Cell 4Neoplasm Metastasis 3Prostatic Neoplasms 2Lung Neoplasms 2Colonic Neoplasms 2Carcinoma, Merkel Cell 2Advanced Non-Small Cell Lung Cancer 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Sarcoma 1Resectable Non-small Cell Lung Cancer 1Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck 1Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Multiple Myeloma 1Mouth Neoplasms 1Motor Activity 1Liposarcoma 1Laryngeal Neoplasms 1Kidney Neoplasms 1

Interventions

pembrolizumab 4Oxaliplatin 4zolbetuximab 2camrelizumab 2apatinib 2S 1 (combination) 2trastuzumab deruxtecan 1tislelizumab 1tepotinib 1relugolix 1lenvatinib 1durvalumab 1dabrafenib 1cemiplimab 1cabazitaxel 1alpha-2'-deoxythioguanosine 1X-Rays 1Vinorelbine 1Surveys and Questionnaires 1Ramucirumab 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiosurgery 1Radiation 1Proton Therapy 1Pemetrexed 1Paclitaxel 1Nivolumab 1Leucovorin 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Adenocarcinoma × cemiplimab × Clear all
NCT05208944 2026-05-13

THIO Sequenced With Cemiplimab in Advanced NSCLC

Maia Biotechnology

Phase 2 Active not recruiting
227 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡